Lamotrigine

• 

  New Zealand Woman "Burned From The Inside" After Severe Reaction From Depression Medication

  Ms Gilmour developed Steven-Johnson syndrome (SJS), a rare condition causing painful blisters on the skin, mouth, and oesophagus.

• 

  Dr Reddy's Launches Seizures Treatment Tablets In US

  Dr Reddy's Laboratories said its product is a generic version of GSK Group of companies' Lamictal tablets.

• 

  Unichem Recalls 368 Bottles Of Anti-Epileptic Drug In US: Report

  The tablets have been manufactured at the company's Goa facility. A single bottle contains 500 tablets of the medicine.

• Dr Reddy's launches anti-epilepsy tablets in US market

  Drug firm Dr Reddy's Laboratories said on Wednesday that it has launched its generic Lamotrigine extended-release tablets in the American market following an approval by the US Food and Drug Administration.

• Wockhardt gets approval to market anti-epilepsy tablets

  Drug firm Wockhardt today said it has received final approval from the US health regulator to market generic lamotrigine tablets - used for treatment of epilepsy - in America.

• Lupin receives FDA approval for Lamotrigine tablets

  Lupin has announced that its U.S subsidiary, Lupin Pharmaceuticals Inc (LPI) has received final approval from U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for its Lamotrigine tablets in strengths of 25 mg, 100 mg, 150 mg and 200 mg.Lupin's Lamotrigine is the AB-rated generic equivalent of GlaxoSmithKline's Lami...

• Lupin receives FDA approval for Lamotrigine tablets

  Lupin has announced that its U.S subsidiary, Lupin Pharmaceuticals Inc (LPI) has received final approval from U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for its Lamotrigine tablets in strengths of 25 mg, 100 mg, 150 mg and 200 mg. Lupin's Lamotrigine is the AB-rated generic equivalent of GlaxoSmithKline's La...

• Lupin receives FDA approval for Lamotrigine tablets

  Lupin has announced that its U.S subsidiary, Lupin Pharmaceuticals Inc (LPI) has received final approval from U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for its Lamotrigine tablets in strengths of 25 mg, 100 mg, 150 mg and 200 mg.Lupin's Lamotrigine is the AB-rated generic equivalent of GlaxoSmithKline's Lami...

• Lupin receives FDA approval for Lamotrigine tablets

  Lupin has announced that its U.S subsidiary, Lupin Pharmaceuticals Inc (LPI) has received final approval from U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for its Lamotrigine tablets in strengths of 25 mg, 100 mg, 150 mg and 200 mg.Lupin's Lamotrigine is the AB-rated generic equivalent of GlaxoSmithKline's Lami...

• Lupin receives FDA approval for Lamotrigine tablets

  Lupin has announced that its U.S subsidiary, Lupin Pharmaceuticals Inc (LPI) has received final approval from U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for its Lamotrigine tablets in strengths of 25 mg, 100 mg, 150 mg and 200 mg.Lupin's Lamotrigine is the AB-rated generic equivalent of GlaxoSmithKline's Lami...

• Lupin receives FDA approval for Lamotrigine tablets

  Lupin has announced that its U.S subsidiary, Lupin Pharmaceuticals Inc (LPI) has received final approval from U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for its Lamotrigine tablets in strengths of 25 mg, 100 mg, 150 mg and 200 mg.Lupin's Lamotrigine is the AB-rated generic equivalent of GlaxoSmithKline's Lami...

• Lupin receives FDA approval for Lamotrigine tablets

  Lupin has announced that its U.S subsidiary, Lupin Pharmaceuticals Inc (LPI) has received final approval from U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for its Lamotrigine tablets in strengths of 25 mg, 100 mg, 150 mg and 200 mg.Lupin's Lamotrigine is the AB-rated generic equivalent of GlaxoSmithKline's Lami...

• Lupin receives FDA approval for Lamotrigine tablets

  Lupin has announced that its U.S subsidiary, Lupin Pharmaceuticals Inc (LPI) has received final approval from U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for its Lamotrigine tablets in strengths of 25 mg, 100 mg, 150 mg and 200 mg.Lupin's Lamotrigine is the AB-rated generic equivalent of GlaxoSmithKline's Lami...

• Lupin receives FDA approval for Lamotrigine

  Lupin receives FDA approval for Lamotrigine tablets Lupin has announced that its U.S subsidiary, Lupin Pharmaceuticals Inc (LPI) has received final approval from U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for its Lamotrigine tablets in strengths of 25 mg, 100 mg, 150 mg and 200 mg. Lupi...

• Lupin Limited - Press Release

  Lupin Limited has informed the Exchange regarding a Press Release dated June 4, 2010 titled "Lupin receives FDA approval for Lamotrigine tablets".